Humana divests minority stake in hospice provider Gentiva
Humana divests minority stake in hospice provider Gentiva June 10 (Reuters) - Humana HUM.N said on Wednesday it has agreed to sell all or substantially all of its minority stake in Gentiva, a provider of hospice and palliative care services, in a deal valuing the stake at about $900 million.
The stake will be sold to a group of investors, Humana said, without disclosing other financial terms.
Humana plans to use the proceeds for general corporate purposes and said the deal is not expected to affect its 2026 earnings.
The transaction is expected to close in the third quarter of 2026, subject to regulatory approvals and other closing conditions.
Gentiva provides hospice care and support for seriously ill patients at more than 430 locations in 35 states.
Humana's Gentiva stake stems from its 2021 Kindred at Home deal, after which it said it would sell non-core hospice and personal care businesses.
In 2022, Humana sold a majority stake in Kindred at Home's hospice and personal care units to private equity firm Clayton, Dubilier & Rice.
(Reporting by Kunal Das in Bengaluru)
((Kunal.Das2@thomsonreuters.com;))
Recent news on Humana
See all newsSwedish care provider Ambea makes recommended $304 million offer for Humana
Brief: Humana Awarded Statewide Illinois Healthchoice Medicaid Contract, Expanding Access To Care Across The State
Brief: Humana Announces Agreement To Divest Minority Interest In Gentiva
Humana divests minority stake in hospice provider Gentiva
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT